Market Access Consolidating data strategy for global success: Insights fro... At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.
Digital Consolidating Digital Health: Insights from Frontiers Health... Rob Milnes (Ultrahuman) connected with pharmaphorum off the Frontiers Health stage to share some insights.
Digital Building a Molecular Time Machine: Insights from Frontiers H... pharmaphorum grabbed a moment with Alkahest Head of Data Science Benoit LeHallier after his talk at Frontiers Health.
Digital Humans in Extremes: Insights from Frontiers Health 2025 pharmaphorum chatted with Jack Kreindler (WellFounded) after his onstage session at Frontiers Health 2025.
Digital Humanity as a Feature, Not a Bug: Insights from Frontiers He... YourCoach Health’s Eugene and Marina Borukhovich spoke with pharmaphorum after their Frontiers Health session.
Digital Transforming Pharma: Insights from Frontiers Health 2025 pharmaphorum caught up with Emre Ozcan (Merck Group) after his onstage session at Frontiers Health.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.